During the last session, SILO Pharma Inc (NASDAQ:SILO)’s traded shares were 0.21 million, with the beta value of the company hitting 1.52. At the end of the trading day, the stock’s price was $0.59, reflecting an intraday loss of -1.92% or -$0.01. The 52-week high for the SILO share is $4.50, that puts it down -662.71 from that peak though still a striking 30.51% gain since the share price plummeted to a 52-week low of $0.41. The company’s market capitalization is $4.27M, and the average trade volume was 915.10K shares over the past three months.

SILO Pharma Inc (NASDAQ:SILO) trade information

SILO Pharma Inc (SILO) registered a -1.92% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -1.92% in intraday trading to $0.59, hitting a weekly high. The stock’s 5-day price performance is 0.41%, and it has moved by 17.54% in 30 days. Based on these gigs, the overall price performance for the year is -46.15%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 11.18%.

SILO Dividends

SILO Pharma Inc is due to release its next quarterly earnings on 2024-Mar-25. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

SILO Pharma Inc (NASDAQ:SILO)’s Major holders

SILO Pharma Inc insiders own 9.50% of total outstanding shares while institutional holders control 3.45%, with the float percentage being 3.81%. VIRTU FINANCIAL LLC is the largest shareholder of the company, while 13.0 institutions own stock in it. As of 2024-06-30, the company held over 41848.0 shares (or 1.3709% of all shares), a total value of $41000.0 in shares.

The next largest institutional holding, with 23938.0 shares, is of FINANCIAL ADVOCATES INVESTMENT MANAGEMENT’s that is approximately 0.7842% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $23938.0.